Abstract
Corticosteroids are commonly used drugs in the treatment of glomerular diseases and renal posttransplantation management. However, long-term use of systemic corticosteroids have substantial
side effects. The association of diabetic ketoacidosis with the use of systemic corticosteroids is
infrequently reported. We report a complication of diabetic ketoacidosis, associated with the use
of high dose corticosteroid for the treatment of focal segmental glomerulosclerosis; which
improved afterthe cessation of steroid therapy.
Keywords: Corticosteroid, focal segmental glomerulosclerosis, diabetic ketoacidosis.
References
- 1. YoshiW. EM, Buczkowski AK. Sim SM, Elliott TG, Scudaınore CH,
- Lcvin A, Tıldesley HD, Landsberg DN. Post-transplant diabetic
- ketoacidosis-ıı. possible coruıequcnce of immunosuppression with
- calcineurininhibitingagents. Tn.nsp1Iııt2000; 13: 69-72.
- 2. Kcshııvarz R, Mousavi M, Hassan C. Diabetic ketoacidosis in a child
- on FK506 immunosuppression arter a liver transplıınt. Pediatr Emerg
- Can: 2002; 18: 22-24.
- 3. Erııoy A, Ersoy C, Tekce H, YAVa.Scııoglu 1, Dilek K. Dia.betic ketoacidosis following devclopment of de nova diabetes in tenal transplant recipient associated with tııcrolimus. Transplıınt Proc 2004;36:
- 1407-1410.
- 4. Toyonaga T, Kondo T,Miyamura N, Selrigami T, Sonoda K, Kodama
- S, Shinıkami A. Shİ1'otani T, Anki E. Sudden onset of diabetes with
- ketoacidosis in a patlent treated with FK506/tacrolimus. Diabetes
- fu:s Clin Ptact2002; 56:13-18.
- 5. www.mdcoruıult.com (Cyclosporine, tacrolimus adverse reactions.
- MDConsult,Drugs).
- 6. O~ Kaya.alp. Tıbbi Farmakoloji Rasyonel Tedavi Yönünden.
- Ankara: Hacettepe-Taş Kitapçılık, 11. Baskı, 2005: 1000-1100.
- 7. Bernatd Schimmeı BP, Parke.r KL. Adenocoıticottopic
- hormone.In:Phannacologic basis of therapeutic. Hardınan JG,
- limited LE, 9tb. ed NewYork,Mc GmwHill İne, 1996; 1459-1486.
- 8. David-Neto E, Lemos FC, Fa.del LM, Agena F, Sata MY, Coccuza. C,
- Percira LM, de Castto MC, Lando VS, Nahas WC, Ianhcz LE. The
- dynamics of glucose metabolism under calcineurin inhibitors in the
- first year aftcr renal transplantatlon in nonobcsc patients. Transplııntatlon 2007; 84: 50-55.
- 9. Dundar B, Eren E, Oktern F, Dundar N, Tunc B, Canatan n Hyperosmolar non-ketotlc sytıdrome in a child associated with 1-ıı.sparaginase and prednisolone. Pediatt lnt 2007; 49: 256-257.
- 10. Yang JY, Cui XL, He XJ Non-ketotlc hyperosmolar coma complicatlng steroid trea.tment in dıildhood nephrosis. Pediatr Nephrol
- 1995;9:621-622.
- 11. Yoshioka K, Sa.ta T, Okada N, Ishii T, Imanishi M, Tanaka S, Kim T,
- Sugimoto T, Fujii S. Post-transplant diabetes with anti-glut:atnic acid
- decarboxykse antibody during tacrolimus therapy. Dia.bet.es Res Oin
- Ptact1998;42: 85-89.
- 12. Agarwall DK, Jeloka T, Sharma AP, Sharma RK. Steroid induccd diabetes mellitus prescntingas diabctic ketoacidosis. Indian J.Ncphrol
- 2002; 12: 122-123.
- 13. Iw.unoto T, Kagawa Y, Naito Y, Kuzuhııra S, Kojima M. Steroid
- induced diabetes mellituıı anıl re.la.ted risk fiı.ctors in patients with
- neurologic discases. Phatmacothctapy 2004; 24: 508-514.
- 14. Banac S, PcrsiC M, Cvijovic K. Steroid diabetes in childrcn with Crohn
- disease. ActaMed Croatica2002; 56: 35-38.
- 15. SpearML,Rceves G, Pearlman SA. Diabetic lretoacidosis after steroid
- administtation for bronchopulmonuydysplasia J Peı:inatol 1993; 13:
- 232-234.
Copyright and license
Copyright © 2008 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.